Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New screws could sharpen cancer imaging and treatment

NCT ID NCT06293157

Disease control Sponsor: Copernicus Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares carbon fiber and titanium screws in people with cancer that has spread to the spine. The goal is to see if carbon screws cause fewer imaging problems, making it easier to plan radiation therapy and spot cancer return. About 226 adults will take part, and the study tracks how long it takes for the cancer to come back after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 226 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Dec 2033

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Metastatic spinal disease, * ECOG quality of life of 0-2, * Eligibility for SBRT treatment, * Expected survival time \>3 months, * Signed informed consent to participate in the study, * Sufficient organ capacity allowing to survive the perioperative period. Exclusion Criteria: * Primary tumor of the spine, * Age \<18 years old, * Expected survival time \<3 months, * Eligibility for palliative radiotherapy, * No informed consent to participate in the study, * Pregnancy or breastfeeding, * The advancement of the disease preventing the technical use of implants.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metastasis spine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

metastatic carcinoma in the bone metastatic malignant neoplasm in the spinal cord metastatic neoplasm Spinal Cord Compression vertebral column disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metastasis spine Metastatic spinal cord compression

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Copernicus Memorial Hospital in Łódź, Poland

    RECRUITING

    Lodz, Łódź Voivodeship, 93-513, Poland

  • Department of Neurosurgery, Functional Neurosurgery and Stereotaxy, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz

    ACTIVE_NOT_RECRUITING

    Bydgoszcz, Poland

  • Department of Teleradiotherapy, Lower Silesian Center of Oncology, Pulmonology and Hematology

    ACTIVE_NOT_RECRUITING

    Wroclaw, Poland

  • Professor Franciszek Łukaszczyk Oncology Center in Bydgoszcz - National Research Institute

    ACTIVE_NOT_RECRUITING

    Bydgoszcz, Poland

  • University Center of Neurology and Neurosurgery, Jan Mikulicz-Radecki University Clinical Hospital in Wrocław

    ACTIVE_NOT_RECRUITING

    Wroclaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.